The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient in a trial suffered a liver injury potentially caused by the drug.

British drugmaker GSK told Manhattan prosecutors that a former employee told colleagues Pfizer held back positive results until after the 2020 election. But the former employee, who worked at both ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director ...

Pfizer's CEO Albert Bourla said that he's had ... health secretary after winning the crucial support of Louisiana Sen. Bill Cassidy, a former physician. Kennedy's nomination cleared a key hurdle ...

Amidst dwindling share prices and widespread criticism, Pfizer CEO Albert Bourla appears to have withstood an attempted ousting by activist investor Starboard Value. On 6 October, Bourla received ...

Albert Bourla, who four years ago led Pfizer through its scientific and financial ... discontinuing active trials of the drug “fits the bill.” Starboard hasn’t publicly disclosed what ...

Pfizer has hired a new oncology commercialization leader to help the business reach its goal of marketing eight blockbuster drugs by 2030. Suneet Varma, currently the commercial president of ...

Kansas on Monday sued Pfizer, accusing the company of misleading the public about its COVID-19 vaccine by hiding risks while making false claims about its effectiveness. In a lawsuit filed in the ...

Pfizer and Flagship Pioneering have settled on the first target for their billion-dollar, multiprogram collaboration, and it’s not exactly a surprise: The New York Big Pharma giant will work ...